Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The picornaviral capsid protein VP1 hydrophobic pocket is a critical structural feature found within the icosahedral shell of viruses in the Picornaviridae family, including rhinoviruses and enteroviruses. This pocket is typically located beneath the floor of a surface depression known as the canyon and is naturally occupied by a fatty acid-like molecule called the pocket factor, which regulates the stability of the viral particle [1][2]. During the infection process, the expulsion of this pocket factor is often a prerequisite for the conformational shifts that lead to viral uncoating and genome release [3]. Therapeutic agents, often referred to as capsid binders or WIN compounds, are designed to occupy this pocket with higher affinity than the natural factor [4]. By filling this cavity, these drugs over-stabilize the capsid, effectively locking it in a state that prevents the release of viral RNA into the host cell cytoplasm [5]. Additionally, drug binding can cause the canyon floor to bulge, potentially interfering with the virus's ability to bind to host cell receptors like ICAM-1 or CD155 [6].
Binding to the hydrophobic pocket stabilizes the viral capsid, preventing the conformational changes required for the release of the viral RNA genome (uncoating) into the host cell. In some cases, drug binding also induces conformational changes in the nearby canyon region, which can sterically hinder the virus from attaching to its cellular receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Picornaviral capsid protein VP1 hydrophobic pocket (VP1 pocket).